LCK (LSK) Antibody - FFPE Validated

About the Target

For consistent comparison across experiments, use this antibody to assess LCK with a repeatable workflow. LCK is a signaling node often evaluated by abundance, localization, and modification-dependent states. For comparison-heavy studies, consistent sample handling and normalization help reduce run-to-run drift.

Monitoring LCK alongside context markers can improve interpretation when phenotypes are subtle.

Research Context

Signaling targets are typically assessed across time courses to capture transient activation windows. Define inclusion criteria and controls early so replicate sets remain interpretable as the dataset grows. In oncology research models, expression shifts can accompany changes in adhesion, signaling, or differentiation state.

Consider these angles when interpreting target-level changes:

• interaction patterns within multi-protein complexes
• localization shifts between cytoplasm, membrane, and nucleus
• time-resolved changes following stimulation or inhibition
• condition-to-condition comparisons with matched controls

Variant Considerations

This fixed-section oriented version is intended for paraffin-embedded tissue, where crosslinking and retrieval steps can shape epitope accessibility. This matters because epitope exposure and background can vary with preparation and extraction steps. Standardize key parameters so differences reflect biology rather than handling.

If your study spans multiple model systems, it can help to define a shared reference condition for LCK so cross-sample contrasts stay meaningful.

For challenging targets, pairing LCK measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

Pair this fixed-section format with stable controls to keep LCK measurements coherent over time.